Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Hib Conjugate Vaccine Trial in Chinese Infants and Young Children
CTR20170277Phase 3Completed
- Sponsor
- Luoyi Biological Technology
- Start
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b disease (Hib), sponsored by Luoyi Biological Technology. Started Apr 2017; status: completed.
02
Drugs
Haemophilus b conjugate vaccine
03
Conditions
Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20170277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170277.